Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HJ Medical Group is a global healthcare organization primarily focused on the medical aesthetics and medical device sectors. The company specializes in the development and manufacturing of hyaluronic acid-based products, most notably the Hyamax line of dermal fillers used for facial contouring and anti-aging treatments. In addition to its aesthetic portfolio, the group provides solutions for orthopedic and ophthalmological applications, including viscoelastics for joint health and surgery. Headquartered in China with a significant international footprint, HJ Medical Group emphasizes research and development to maintain its position in the competitive global medical aesthetics market. The company's products are distributed in over 70 countries, adhering to international quality standards such as CE and ISO certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HJ Medical Group.